Clinical Trials Directory

Trials / Completed

CompletedNCT02536105

PK/PD Pediatric ADHD Classroom Study

Pharmacokinetic Pharmacodynamic Studies of Methylphenidate Extended Release Products in Pediatric Attention Deficit Hyperactivity Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
88 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
6 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the association between blood drug levels and the corresponding scores of commonly used behavioral instruments based upon data collected following administration of three different methylphenidate hydrochloride extended-release drug products in children with ADHD.

Detailed description

This is a randomized, double-blind, 4-treatment and 4-period crossover study conducted in a school laboratory environment to evaluate the hour-by-hour behavioral instrument scores and hour-by-hour PK of 3 different extended-release MPH formulations as well as placebo in children with ADHD. The complete study consists of three periods: Screening, Dose Titration and Double-Blind Crossover in a Laboratory Classroom. The double-blind phase will consist of four periods (or four weeks): each week will consist of blinded administration with one of the three active methylphenidate hydrochloride treatments or placebo from Sunday through Saturday. On the last day of each period (Saturday), study participants will be evaluated in a laboratory classroom setting. On Saturdays, the blinded doses of each study drug will be administered at the school site by study staff on the morning of the test laboratory classroom day. On the other days, the medication will be taken in the morning at home.

Conditions

Interventions

TypeNameDescription
DRUGMethylphenidate HCl ER tablets 1
DRUGPlacebo
DRUGMethylphenidate HCl ER tablets 2
DRUGMethylphenidate HCl ER for suspension

Timeline

Start date
2016-05-01
Primary completion
2018-07-01
Completion
2018-07-01
First posted
2015-08-31
Last updated
2019-12-10
Results posted
2019-12-10

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02536105. Inclusion in this directory is not an endorsement.